Nexalin Technology, Inc. Common Stock

NXLNASDAQ • USD
ThemeMedical Devices & HealthTech›Neuromodulation & Neurology
0.36 USD
↘ 0.00 (1.07%)AT CLOSE (11:59 AM EDT)
0.37
↗ 0.00 (1.11%)
POST MARKET (AS OF 06:53 PM EDT)
Post Market
AS OF 06:53 PM EDT
0.37
↗ 0.00 (1.11%)
🔴Market: CLOSED

Nexalin Technology, Inc. Common Stock (NXL) trades at $0.38 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. NXL is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Aug 4, 2026.

Open?$0.36
High?$0.41
Low?$0.36
Prev. Close?$0.36
Volume?173.8K
Avg. Volume?261.6K
VWAP?$0.38
Rel. Volume?0.66x
Bid / Ask
Bid?$0.31 × 100
Ask?$0.45 × 100
Spread?$0.14
Midpoint?$0.38
Valuation & Ratios
Market Cap?7.9M
Shares Out?22.0M
Float?16.5M
Float %?80.0%
P/E Ratio?N/A
P/B Ratio?2.75
EPS?-$0.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the US and China, with China generating the maximum sales.
Themes
Medical Devices & HealthTech›Neuromodulation & NeurologyDigital Health & Telemedicine›Digital Therapeutics
Employees
8
Market Cap
8.0M
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Website
www.nexalin.com
Listed
2022-09-16
Address
1776 YORKTOWN
HOUSTON, TX 77056
Phone: (832) 260-0222
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
65
Short Sent.?
45
Piotroski F-Score?1/9Weak
Altman Z-Score?-36.81Distress
Confidence?52%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.98%Low
Short Interest?655.0K
Days to Cover?2.0
Free Float16.5M
Avg Daily Volume330.8K
Settlement Date2026-07-15
Financial Health
Current Ratio?4.07Strong
Quick Ratio?3.85Strong
Cash Ratio?1.49Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
60
2.75CHEAP▾
P/S?
Peers
100
S&P
3
28.75HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.8CHEAP▾
EV/Sales?
Peers
100
S&P
3
24.37HIGH▾
Returns & Efficiency
ROE?
S&P
3
-288.6%WEAK▾
ROA?
S&P
3
-225.5%WEAK▾
Cash Flow & Enterprise
FCF?$-5293708
Enterprise Value?$6.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist